Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 29, 2005

View Archived Issues

Isotechnika sees progress on multiple fronts

MSA proves to be beneficial for the treatment of lymphomas

Vildagliptin safely lowers HbA1c levels in patients with type 2 diabetes

Savient terminates Prosaptide development efforts

InterMune sells oritavancin rights to Targanta Therapeutics

Enrollment closes in PRECISE trial of cintredekin besudotox

Animal study begins for Acusolin for cataracts

ChimeriVax-West Nile vaccine enters phase II

Novartis seeks Japanese approval for Glivec in Ph+ ALL

Wyeth and Progenics collaborate on development of methylnaltrexone

Able Laboratories sells assets to Sun Pharmaceutical Industries

Synta outlines development priorities in 2006

Positive preliminary results from study of TRANSDUR-Sufentanil patch

Recent Pfizer patent discloses new anxiolytics

New beta-adrenoceptor antagonists for eye disorders reported by Othera

Novel therapeutic agents for respiratory disorders claimed in recent patents

Results of a phase III trial evaluating human papillomavirus vaccination with Gardasil

NDA submitted for protease inhibitor TMC-114

Revlimid receives FDA approval

Insights into Cdk1 inhibition and mitotic timing

Ranolazine improves exercise ability in diabetic angina patients

Benefit of eculizumab in paroxysmal nocturnal hemoglobinuria seen at 3 years

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...